A new target for the treatment of schizophrenia

Brain and Spine Institute. France: The Biotechnology & Biotherapy team, created by Dr. Jacques Mallet and presently directed by Dr. Philippe Ravassard, at the Brain and Spine Institute (ICM), in collaboration with the Pole of Therapeutic Innovation in Neuropsychiatry at the Servier Research Institute, has shown that the local inactivation of Gpr88, a new receptor expressed exclusively in the brain, normalizes some behaviors altered in a model of schizophrenia.

Schizophrenia

NIH. US: Schizophrenia is a chronic, severe, and disabling brain disorder that has affected people throughout history. People with the disorder may hear voices other people don't hear. They may believe other people are reading their minds, controlling their thoughts, or plotting to harm them. This can terrify people with the illness and make them withdrawn or extremely agitated.
People with schizophrenia may not make sense when they talk. They may sit for hours without moving or talking. Sometimes people with schizophrenia seem perfectly fine until they talk about what they are really thinking.